Immune Enhancement Therapy

  • Vladimir V. Klimov


The reader can find the information on medications used for the immune enhancement therapy for immunocompromised conditions, which take place in the pathology of a wide array of involved organs and tissues of the human body and must be a useful tool for practitioners. It should be noted this critical topic is very rare in immunology manuals.

Supplementary material

466144_1_En_9_MOESM1_ESM.mp3 (6.4 mb)
Audio 9.1 (MP3 6539 kb)



  1. JTK H, GCF C, JCB L. Systemic effects of gut microbiota and its relationship with disease and modulation. BMC Immunol. 2015;16(21):1–6. Scholar
  2. Mitrevski M, Marrapodi R, Camponeschi A, Cavaliere FM, Lazzeri C, Todi L, Visentini M. Intravenous immunoglobulin and immunomodulation of B-cell – in vitro and in vivo effects. Front Immunol. 2015;6(4):1–5. Scholar
  3. Ogra PL, Faden H, Welliver RC. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev. 2001;14(2):430–45.–445.2001.CrossRefPubMedPubMedCentralGoogle Scholar

Landmark Papers

  1. Li C, Bo L, Liu Q, Jin F. Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis. Int J Infect Dis. 2015;33:90–6. Scholar
  2. Villa E, Garelli V, Braido F, Melioli G, Canonica GW. May we strengthen the human natural defenses with bacterial lysates? World Allergy Organ J. 2010;3(2):17–23.Google Scholar

Suggested Reading

  1. Ancell CD, Phipps J, Young L. Thymosin alpha-1. Am J Health Syst Pharm. 2001;58(10):879–85.CrossRefGoogle Scholar
  2. Andreone P, Cursaro C, Gramenzi A, et al. In vitro effect of thymosin-a1 and interferon-a on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C. J Viral Hepat. 2001;8:194–201.CrossRefGoogle Scholar
  3. Ashraf R, Shah NP. Immune system stimulation by probiotic microorganisms. Crit Rev Food Sci Nutr. 2014;54(7):938–56. Scholar
  4. Durmont F, de Villemeur M. Implementing immunostimulants. Eur Biopharm Rev. 2011;12(155):2988.Google Scholar
  5. Kedl JD, Kedl RM. How squalene GLAdly helps generate antigen-specific T cells via antigen-carrying neutrophils and IL-18. Eur J Immunol. 2015;45(2):376–9. Scholar
  6. Killip MJ, Fodor E, Randall RE. Influenza virus activation of the interferon system. Virus Res. 2015;209:11–22. Scholar
  7. Klaenhammer TR, Kleerebezem M, Kopp MV, Rescigno M. The impact of probiotics and prebiotics on the immune system. Nat Rev Immunol. 2012;12:728–34. Scholar
  8. Kotredes KP, Thomas B, Gamero AM. The protective role of type I interferon in the gastrointestinal tract. Front Immunol. 2017;8(410):1–24. Scholar
  9. Li C-L, Zhang T, Saibara T, Nemoto Y, Ono M, Akisawa N, Iwasaki S, Maeda T, Onishi S. Thymosin a1 accelerates restoration of T cell-mediated neutralizing antibody response in immunocompromised hosts. Int Immunopharmacol. 2002;2:39–46.CrossRefGoogle Scholar
  10. Lucas RM, Gorman S, Geldenhuys S, Hart PH. Vitamin D and immunity. F1000Prime Rep. 2014;6(118):1–11. Scholar
  11. Monroe KM, McWhirter SM, Vance RE. Induction of type I interferons by bacteria. Cell Microbiol. 2010;12(7):881–90. Scholar
  12. Ningrum RA. Human interferon alpha-2b: a therapeutic protein for cancer treatment. Scientifica. 2014;970(315):1–8. Scholar
  13. Peter JG, Heckmann JM, Novitzky N. Recommendations for the use of immunoglobulin therapy for immunomodulation and antibody replacement. S Afr Med J. 2014;104(11):796–805. Scholar
  14. Srivastava A, Gowda DV, Madhunapantula SV, Shinde CG, Iyer M. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles. APMIS. 2015;123(4):275–88. Scholar
  15. Seton-Rogers S. Immunotherapy: powerful combinations. Nat Rev Cancer. 2016;16:757–69. Scholar
  16. Silin DS, Lyubomska OV, Ershov FI, Frolov VM, Kutsyna GA. Synthetic and natural immunomodulators acting as interferon inducers. Curr Pharm Des. 2009;15(11):1238–47.CrossRefGoogle Scholar
  17. Wolf E, Milazzo S, Boehm K, Zwahlen M, Horneber M. Thymic peptides for treatment of cancer patients. Cochrane Database Syst Rev. 2011;2(CD003993)

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Vladimir V. Klimov
    • 1
  1. 1.Clinical Immunology and Allergy DepartmentSiberian State Medical UniversityTomskRussia

Personalised recommendations